[1]
|
Ng, S.C., Shi, H.Y., Hamidi, N., Underwood, F.E., Tang, W., Benchimol, E.I., Panaccione, R., Ghosh, S., Wu, J.C.Y., Chan, F.K.L., Sung, J.J.Y. and Kaplan, G.G. (2017) Worldwide Incidence and Prevalence of Inflammatory Bowel Dis-ease in the 21st Century: A Systematic Review of Population-Based Studies. Lancet, 390, 2769-2778.
https://doi.org/10.1016/S0140-6736(17)32448-0
|
[2]
|
Pasquali, S. and Gronchi, A. (2017) Neoadjuvant Chemo-therapy in Soft Tissue Sarcomas: Latest Evidence and Clinical Implications. Therapeutic Advances in Medical Oncology, 9, 415-429. https://doi.org/10.1177/1758834017705588
|
[3]
|
Ye, Q., Zou, B., Yeo, Y.H., Li, J., Huang, D.Q., Wu, Y., Yang, H., Liu, C., Kam, L.Y., Tan, X.X.E., Chien, N., Trinh, S., Henry, L., Stave, C.D., Hosaka, T., Cheung, R.C. and Nguyen, M.H. (2020) Global Prevalence, Incidence, and Outcomes of Non-Obese or Lean Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. The Lancet Gastroenterology and Hepatology, 5, 739-752. https://doi.org/10.1016/S2468-1253(20)30077-7
|
[4]
|
Schwabe, R.F., Tabas, I. and Pajvani, U.B. (2020) Mecha-nisms of Fibrosis Development in Nonalcoholic Steatohepatitis. Gastroenterology, 158, 1913-1928. https://doi.org/10.1053/j.gastro.2019.11.311
|
[5]
|
Hardy, T., Oakley, F., Anstee, Q.M. and Day, C.P. (2016) Non-alcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. Annual Review of Pathology: Mechanisms of Disease, 11, 451-496.
https://doi.org/10.1146/annurev-pathol-012615-044224
|
[6]
|
Zamani, M., Alizadeh-Tabari, S., Singh, S. and Loomba, R. (2022) Meta-Analysis: Prevalence Of, and Risk Factors For, Non-Alcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease. Alimentary Pharmacology & Therapeutics, 55, 894-907. https://doi.org/10.1111/apt.16879
|
[7]
|
Perdomo, C.M., Frühbeck, G. and Escalada, J. (2019) Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease. Nutrients, 11, Article No. 677. https://doi.org/10.3390/nu11030677
|
[8]
|
Zhao, H., Yang, A., Mao, L., Quan, Y., Cui, J. and Sun, Y. (2020) As-sociation between Dietary Fiber Intake and Non-Alcoholic Fatty Liver Disease in Adults. Frontiers in Nutrition, 7, Arti-cle 593735.
https://doi.org/10.3389/fnut.2020.593735
|
[9]
|
Suk, K.T. and Kim, D.J. (2019) Gut Microbiota: Novel Therapeutic Target for Nonalcoholic Fatty Liver Disease. Expert Review of Gastroenterology & Hepatology, 13, 193-204. https://doi.org/10.1080/17474124.2019.1569513
|
[10]
|
Zhang, Z., Thorne, J.L. and Moore, J.B. (2019) Vitamin D and Nonalcoholic Fatty Liver Disease. Current Opinion in Clinical Nutrition and Metabolic Care, 22, 449-458. https://doi.org/10.1097/MCO.0000000000000605
|
[11]
|
Reilly, N.R., Lebwohl, B., Hultcrantz, R., Green, P.H. and Ludvigsson, J.F. (2015) Increased Risk of Non-Alcoholic Fatty Liver Disease after Diagnosis of Celiac Disease. Journal of Hepatology, 62, 1405-1411.
https://doi.org/10.1016/j.jhep.2015.01.013
|
[12]
|
Kang, M.K., Kim, K.O., Kim, M.C., Park, J.G. and Jang, B.I. (2020) Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Dis-ease. Digestive Diseases, 38, 507-514.
https://doi.org/10.1159/000506938
|
[13]
|
Ampong, I., Watkins, A., Gutierrez-Merino, J., Ikwuobe, J. and Griffiths, H.R. (2020) Dietary Protein Insufficiency: An Important Consideration in Fatty Liver Disease? The British Journal of Nutrition, 123, 601-609.
https://doi.org/10.1017/S0007114519003064
|
[14]
|
Pälve, K.S., Pahkala, K., Suomela, E., Aatola, H., Hulkkonen, J., Juonala, M., Lehtimäki, T., Rönnemaa, T., Viikari, J.S.A., Kähönen, M., Hutri-Kähönen, N., Telama, R., Tammelin, T. and Raitakari, O.T. (2017) Cardiorespiratory Fitness and Risk of Fatty Liver: The Young Finns Study. Medicine & Sci-ence in Sports & Exercise, 49, 1834-1841.
https://doi.org/10.1249/MSS.0000000000001288
|
[15]
|
Partridge, D., Lloyd, K.A., Rhodes, J.M., Walker, A.W., Johnstone, A.M. and Campbell, B.J. (2019) Food Additives: Assessing the Impact of Exposure to Permitted Emulsifiers on Bowel and Metabolic Health—Introducing the FADiets Study. Nutrition Bulletin, 44, 329-349. https://doi.org/10.1111/nbu.12408
|
[16]
|
Aron-Wisnewsky, J., Warmbrunn, M.V., Nieuwdorp, M. and Clément, K. (2020) Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity? Gastroenterology, 158, 1881-1898.
https://doi.org/10.1053/j.gastro.2020.01.049
|
[17]
|
Likhitsup, A., Dundulis, J., Ansari, S., El-Halawany, H., Mi-chelson, R., Hutton, C., Kennedy, K., Helzberg, J.H. and Chhabra, R. (2019) Prevalence of Non-Alcoholic Fatty Liver Disease on Computed Tomography in Patients with Inflammatory Bowel Disease Visiting an Emergency Department. Annals of Gastroenterology, 32, 283-286.
https://doi.org/10.20524/aog.2019.0371
|
[18]
|
McCracken, E., Monaghan, M. and Sreenivasan, S. (2018) Patho-physiology of the Metabolic Syndrome. Clinics in Dermatology, 36, 14-20. https://doi.org/10.1016/j.clindermatol.2017.09.004
|
[19]
|
Yorulmaz, E., Adali, G., Yorulmaz, H., Ulasoglu, C., Ta-san, G. and Tuncer, I. (2011) Metabolic Syndrome Frequency in Inflammatory Bowel Diseases. Saudi Journal of Gas-troenterology, 17, 376-382.
https://doi.org/10.4103/1319-3767.87177
|
[20]
|
Fröhlich, M., Imhof, A., Berg, G., Hutchinson, W.L., Pepys, M.B., Boeing, H., Muche, R., Brenner, H. and Koenig, W. (2000) Association between C-Reactive Protein and Features of the Metabolic Syndrome: A Population-Based Study. Diabetes Care, 23, 1835-1839. https://doi.org/10.2337/diacare.23.12.1835
|
[21]
|
Barron, L., Courtney, C., Bao, J., Onufer, E., Panni, R.Z., Aladeg-bami, B. and Warner, B.W. (2018) Intestinal Resection-Associated Metabolic Syndrome. Journal of Pediatric Surgery, 53, 1142-1147.
https://doi.org/10.1016/j.jpedsurg.2018.02.077
|
[22]
|
Allard, J., Le Guillou, D., Begriche, K. and Fromenty, B. (2019) Drug-Induced Liver Injury in Obesity and Nonalcoholic Fatty Liver Disease. Advances in Pharmacology, 85, 75-107. https://doi.org/10.1016/bs.apha.2019.01.003
|
[23]
|
Nielsen, O.H. and Ainsworth, M.A. (2013) Tumor Ne-crosis Factor Inhibitors for Inflammatory Bowel Disease. The New England Journal of Medicine, 369, 754-762. https://doi.org/10.1056/NEJMct1209614
|
[24]
|
Ben-Horin, S., Kopylov, U. and Chowers, Y. (2014) Optimizing Anti-TNF Treatments in Inflammatory Bowel Disease. Autoimmunity Reviews, 13, 24-30. https://doi.org/10.1016/j.autrev.2013.06.002
|
[25]
|
Nakase, H., Hirano, T., Wagatsuma, K., Ichimiya, T., Yamakawa, T., Yokoyama, Y., Hayashi, Y., Hirayama, D., Kazama, T., Yoshii, S. and Yamano, H.-O. (2021) Artificial Intelli-gence-Assisted Endoscopy Changes the Definition of Mucosal Healing in Ulcerative Colitis. Digestive Endoscopy, 33, 903-911. https://doi.org/10.1111/den.13825
|
[26]
|
Neurath, M.F. (2014) New Targets for Mucosal Healing and Therapy in Inflammatory Bowel Diseases. Mucosal Immunology, 7, 6-19. https://doi.org/10.1038/mi.2013.73
|
[27]
|
Okamoto, R. and Watanabe, M. (2016) Investigating Cell Therapy for In-flammatory Bowel Disease. Expert Opinion on Biological Therapy, 16, 1015-1023. https://doi.org/10.1080/14712598.2016.1177019
|
[28]
|
van der Windt, D.J., Sud, V., Zhang, H., Tsung, A. and Huang, H. (2018) The Effects of Physical Exercise on Fatty Liver Disease. Gene Expression, 18, 89-101.
|
[29]
|
Ji, H.-F., Sun, Y. and Shen, L. (2014) Effect of Vitamin E Supplementation on Aminotransferase Levels in Patients with NAFLD, NASH, and CHC: Results from a Meta-Analysis. Nutrition, 30, 986-991.
https://doi.org/10.1016/j.nut.2014.01.016
|